Instylla is focused on developing next-generation liquid embolics for interventional radiology, with initial clinical applications in interventional oncology and peripheral hemostasis.
Caution: Investigational Device. Limited by Federal (or US) law to Investigational use only. Not available for sale.
Company Details
- Employees
- 47
- Founded
- -
- Address
- 201 Burlington Rd, Bedford,massachusetts 01730,united States
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- https://www.instylla.com/
- Keywords
- Interventional Radiology, Interventional Oncology, Hemorrhage Control, Embolization Technology, Liquid Embolics, Peripheral Hemostasis.
- HQ
- Bedford, Massachusetts
Instylla Questions
Instylla's website is https://www.instylla.com/
Instylla's LinkedIn profile is https://www.linkedin.com/company/instylla
Instylla has
47 employees.
View email and phone details for 47
employees at Instylla.
Instylla's industry is
Medical Equipment Manufacturing
Instylla's top competitors are
Deroyal,
Rejoni, Inc,
Imperative Care,
Pramand Llc,
Tulavi,
Ocular Therapeutix, Inc.,
Via Global Health,
Fluidx Medical Technology, Inc.,
Sealonix,
Verge Medical.
Instylla's categories are Medical Equipment Manufacturing
Instylla's founding year is 2017
